Skip to main content
Top
Published in: Digestive Diseases and Sciences 2/2016

01-02-2016 | Original Article

Risk Factors Associated with Rebleeding in Patients with High Risk Peptic Ulcer Bleeding: Focusing on the Role of Second Look Endoscopy

Authors: Sung Bum Kim, Si Hyung Lee, Kyeong Ok Kim, Byung Ik Jang, Tae Nyeun Kim, Seong Woo Jeon, Joong Goo Kwon, Eun Young Kim, Jin Tae Jung, Kyung Sik Park, Kwang Bum Cho, Eun Soo Kim, Hyun Jin Kim, Chang Keun Park, Jeong Bae Park, Chang Heon Yang

Published in: Digestive Diseases and Sciences | Issue 2/2016

Login to get access

Abstract

Background

Re-bleeding after initial hemostasis in peptic ulcer bleeding can be life threatening. Identification of factors associated with re-bleeding is important. The aims of this study were to determine incidence of rebleeding in patients with high risk peptic ulcer bleeding and to evaluate factors associated with rebleeding.

Methods

Among patients diagnosed as upper gastrointestinal hemorrhage at seven hospitals in Daegu–Gyeongbuk, and one hospital in Gyeongnam, South Korea, from Feb 2011 to Dec 2013, 699 patients diagnosed as high risk peptic ulcer bleeding with Forrest classification above llb were included. The data were obtained in a prospective manner.

Results

Among 699 patients, re-bleeding occurred in 64 (9.2 %) patients. Second look endoscopy was significantly more performed in the non-rebleeding group than the rebleeding group (81.8 vs 62.5 %, p < 0.001). In multivariate analysis, use of non-steroidal anti-inflammatory agents, larger transfusion volume (≥5 units), and non-performance of second look endoscopy were found as risk factors for rebleeding in high risk peptic ulcer bleeding.

Conclusion

In our study, rebleeding was observed in 9.2 % of patients with high risk peptic ulcer bleeding. Performance of second look endoscopy seems to lower the risk of rebleeding in high risk peptic ulcer bleeding patients and caution should be paid to patients receiving high volume transfusion and on medication with NSAIDs.
Literature
1.
go back to reference Boonpongmanee S, Fleischer DE, Pezzullo JC, et al. The frequency of peptic ulcer as a cause of upper-GI bleeding is exaggerated. Gastrointest Endosc. 2004;59:788–794.CrossRefPubMed Boonpongmanee S, Fleischer DE, Pezzullo JC, et al. The frequency of peptic ulcer as a cause of upper-GI bleeding is exaggerated. Gastrointest Endosc. 2004;59:788–794.CrossRefPubMed
2.
go back to reference Jutabha R, Jensen DM. Management of upper gastrointestinal bleeding in the patient with chronic liver disease. Med Clin North Am. 1996;80:1035–1068.CrossRefPubMed Jutabha R, Jensen DM. Management of upper gastrointestinal bleeding in the patient with chronic liver disease. Med Clin North Am. 1996;80:1035–1068.CrossRefPubMed
3.
go back to reference Longstreth GF. Epidemiology of hospitalization for acute upper gastrointestinal hemorrhage: A population-based study. Am J Gastroenterol. 1995;90:206–210.PubMed Longstreth GF. Epidemiology of hospitalization for acute upper gastrointestinal hemorrhage: A population-based study. Am J Gastroenterol. 1995;90:206–210.PubMed
5.
go back to reference Silverstein FE, Gilbert DA, Tedesco FJ, Buenger NK, Persing J. The national ASGE survey on upper gastrointestinal bleeding: II. Clinical prognostic factors. Gastrointest Endosc. 1981;27:80–93.CrossRefPubMed Silverstein FE, Gilbert DA, Tedesco FJ, Buenger NK, Persing J. The national ASGE survey on upper gastrointestinal bleeding: II. Clinical prognostic factors. Gastrointest Endosc. 1981;27:80–93.CrossRefPubMed
6.
go back to reference Barkun A, Sabbah S, Enns R, et al. The Canadian Registry on Nonvariceal Upper Gastrointestinal Bleeding and Endoscopy (RUGBE): Endoscopic hemostasis and proton pump inhibition are associated with improved outcomes in a real-life setting. Am J Gastroenterol. 2004;99:1238–1246.CrossRefPubMed Barkun A, Sabbah S, Enns R, et al. The Canadian Registry on Nonvariceal Upper Gastrointestinal Bleeding and Endoscopy (RUGBE): Endoscopic hemostasis and proton pump inhibition are associated with improved outcomes in a real-life setting. Am J Gastroenterol. 2004;99:1238–1246.CrossRefPubMed
7.
go back to reference Lu Y, Chen YI, Barkun A. Endoscopic management of acute peptic ulcer bleeding. Gastroenterol Clin North Am. 2014;43:677–705.CrossRefPubMed Lu Y, Chen YI, Barkun A. Endoscopic management of acute peptic ulcer bleeding. Gastroenterol Clin North Am. 2014;43:677–705.CrossRefPubMed
8.
go back to reference Forrest JA, Finlayson ND, Shearman DJ. Endoscopy in gastrointestinal bleeding. Lancet. 1974;2:394–397.CrossRefPubMed Forrest JA, Finlayson ND, Shearman DJ. Endoscopy in gastrointestinal bleeding. Lancet. 1974;2:394–397.CrossRefPubMed
9.
go back to reference Rockall TA, Logan RF, Devlin HB, Northfield TC. Selection of patients for early discharge or outpatient care after acute upper gastrointestinal haemorrhage. National audit of acute upper gastrointestinal haemorrhage. Lancet. 1996;347:1138–1140.CrossRefPubMed Rockall TA, Logan RF, Devlin HB, Northfield TC. Selection of patients for early discharge or outpatient care after acute upper gastrointestinal haemorrhage. National audit of acute upper gastrointestinal haemorrhage. Lancet. 1996;347:1138–1140.CrossRefPubMed
10.
go back to reference Ramsoekh D, van Leerdam ME, Rauws EA, Tytgat GN. Outcome of peptic ulcer bleeding, nonsteroidal anti-inflammatory drug use, and helicobacter pylori infection. Clin Gastroenterol Hepatol. 2005;3:859–864.CrossRefPubMed Ramsoekh D, van Leerdam ME, Rauws EA, Tytgat GN. Outcome of peptic ulcer bleeding, nonsteroidal anti-inflammatory drug use, and helicobacter pylori infection. Clin Gastroenterol Hepatol. 2005;3:859–864.CrossRefPubMed
11.
go back to reference Cheng CL, Lin CH, Kuo CJ, et al. Predictors of rebleeding and mortality in patients with high-risk bleeding peptic ulcers. Dig Dis Sci. 2010;55:2577–2583.CrossRefPubMed Cheng CL, Lin CH, Kuo CJ, et al. Predictors of rebleeding and mortality in patients with high-risk bleeding peptic ulcers. Dig Dis Sci. 2010;55:2577–2583.CrossRefPubMed
12.
go back to reference Lin HJ, Hsieh YH, Tseng GY, Perng CL, Chang FY, Lee SD. A prospective, randomized trial of large- versus small-volume endoscopic injection of epinephrine for peptic ulcer bleeding. Gastrointest Endosc. 2002;55:615–619.CrossRefPubMed Lin HJ, Hsieh YH, Tseng GY, Perng CL, Chang FY, Lee SD. A prospective, randomized trial of large- versus small-volume endoscopic injection of epinephrine for peptic ulcer bleeding. Gastrointest Endosc. 2002;55:615–619.CrossRefPubMed
13.
go back to reference El Ouali S, Barkun AN, Wyse J, et al. Is routine second-look endoscopy effective after endoscopic hemostasis in acute peptic ulcer bleeding? A meta-analysis. Gastrointest Endosc. 2012;76:283–292.CrossRefPubMed El Ouali S, Barkun AN, Wyse J, et al. Is routine second-look endoscopy effective after endoscopic hemostasis in acute peptic ulcer bleeding? A meta-analysis. Gastrointest Endosc. 2012;76:283–292.CrossRefPubMed
14.
go back to reference Villanueva C, Colomo A, Bosch A, et al. Transfusion strategies for acute upper gastrointestinal bleeding. N Engl J Med. 2013;368:11–21.CrossRefPubMed Villanueva C, Colomo A, Bosch A, et al. Transfusion strategies for acute upper gastrointestinal bleeding. N Engl J Med. 2013;368:11–21.CrossRefPubMed
15.
go back to reference Jaramillo JL, Galvez C, Carmona C, Montero JL, Mino G. Prediction of further hemorrhage in bleeding peptic ulcer. Am J Gastroenterol. 1994;89:2135–2138.PubMed Jaramillo JL, Galvez C, Carmona C, Montero JL, Mino G. Prediction of further hemorrhage in bleeding peptic ulcer. Am J Gastroenterol. 1994;89:2135–2138.PubMed
16.
go back to reference Barkun A, Bardou M, Marshall JK. Nonvariceal Upper GIBCCG. Consensus recommendations for managing patients with nonvariceal upper gastrointestinal bleeding. Ann Intern Med. 2003;139:843–857.CrossRefPubMed Barkun A, Bardou M, Marshall JK. Nonvariceal Upper GIBCCG. Consensus recommendations for managing patients with nonvariceal upper gastrointestinal bleeding. Ann Intern Med. 2003;139:843–857.CrossRefPubMed
17.
go back to reference Lin HJ, Wang K, Perng CL, Lee FY, Lee CH, Lee SD. Natural history of bleeding peptic ulcers with a tightly adherent blood clot: a prospective observation. Gastrointest Endosc. 1996;43:470–473.CrossRefPubMed Lin HJ, Wang K, Perng CL, Lee FY, Lee CH, Lee SD. Natural history of bleeding peptic ulcers with a tightly adherent blood clot: a prospective observation. Gastrointest Endosc. 1996;43:470–473.CrossRefPubMed
18.
go back to reference Lin HJ, Perng CL, Lee FY, Lee CH, Lee SD. Clinical courses and predictors for rebleeding in patients with peptic ulcers and non-bleeding visible vessels: a prospective study. Gut. 1994;35:1389–1393.PubMedCentralCrossRefPubMed Lin HJ, Perng CL, Lee FY, Lee CH, Lee SD. Clinical courses and predictors for rebleeding in patients with peptic ulcers and non-bleeding visible vessels: a prospective study. Gut. 1994;35:1389–1393.PubMedCentralCrossRefPubMed
19.
go back to reference van Leerdam ME, Vreeburg EM, Rauws EA, et al. Acute upper GI bleeding: Did anything change? Time trend analysis of incidence and outcome of acute upper GI bleeding between 1993/1994 and 2000. Am J Gastroenterol. 2003;98:1494–1499.CrossRefPubMed van Leerdam ME, Vreeburg EM, Rauws EA, et al. Acute upper GI bleeding: Did anything change? Time trend analysis of incidence and outcome of acute upper GI bleeding between 1993/1994 and 2000. Am J Gastroenterol. 2003;98:1494–1499.CrossRefPubMed
20.
go back to reference Brullet E, Campo R, Bedos G, Barcons S, Gubern JM, Bordas JM. Site and size of bleeding peptic ulcer. Is there any relation to the efficacy of hemostatic sclerotherapy? Endoscopy. 1991;23:73–75.CrossRefPubMed Brullet E, Campo R, Bedos G, Barcons S, Gubern JM, Bordas JM. Site and size of bleeding peptic ulcer. Is there any relation to the efficacy of hemostatic sclerotherapy? Endoscopy. 1991;23:73–75.CrossRefPubMed
Metadata
Title
Risk Factors Associated with Rebleeding in Patients with High Risk Peptic Ulcer Bleeding: Focusing on the Role of Second Look Endoscopy
Authors
Sung Bum Kim
Si Hyung Lee
Kyeong Ok Kim
Byung Ik Jang
Tae Nyeun Kim
Seong Woo Jeon
Joong Goo Kwon
Eun Young Kim
Jin Tae Jung
Kyung Sik Park
Kwang Bum Cho
Eun Soo Kim
Hyun Jin Kim
Chang Keun Park
Jeong Bae Park
Chang Heon Yang
Publication date
01-02-2016
Publisher
Springer US
Published in
Digestive Diseases and Sciences / Issue 2/2016
Print ISSN: 0163-2116
Electronic ISSN: 1573-2568
DOI
https://doi.org/10.1007/s10620-015-3846-y

Other articles of this Issue 2/2016

Digestive Diseases and Sciences 2/2016 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.